These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28249042)

  • 21. DAPK promoter methylation status correlates with tumor metastasis and poor prognosis in patients with non-small cell lung cancer.
    Zhang J; Yu XL; Zheng GF; Zhao F
    Cancer Biomark; 2015; 15(5):609-17. PubMed ID: 26406950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of death-associated protein kinase gene and methylation status of promoter region in acute leukemia].
    Niu YM; Wang PP; Wang Y; Wang YZ; Cai DL; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):30-4. PubMed ID: 24598646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer.
    Sun W; Zaboli D; Wang H; Liu Y; Arnaoutakis D; Khan T; Khan Z; Koch WM; Califano JA
    Clin Cancer Res; 2012 Feb; 18(4):1082-91. PubMed ID: 22228635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Death-associated protein kinase promoter (DAPK) hypermethylation in uterine cervical cancer and intraepithelial neoplasia in Uyghur nationality women].
    Niyazi M; Liu XW; Zhu KC
    Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):31-4. PubMed ID: 22490852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Promoter methylation of DAPK gene in cervical carcinoma].
    Zhao XL; Meng ZY; Qiao YH; Zhang HL
    Ai Zheng; 2008 Sep; 27(9):919-23. PubMed ID: 18799028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance.
    Ogawa T; Liggett TE; Melnikov AA; Monitto CL; Kusuke D; Shiga K; Kobayashi T; Horii A; Chatterjee A; Levenson VV; Koch WM; Sidransky D; Chang X
    Cell Cycle; 2012 Apr; 11(8):1656-63. PubMed ID: 22487682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of methylation markers for diagnosis of oral cavity cancer.
    Arantes LM; de Carvalho AC; Melendez ME; Centrone CC; Góis-Filho JF; Toporcov TN; Caly DN; Tajara EH; Goloni-Bertollo EM; Carvalho AL;
    Eur J Cancer; 2015 Mar; 51(5):632-41. PubMed ID: 25686481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma.
    Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W
    Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).
    Niklinska W; Naumnik W; Sulewska A; Kozłowski M; Pankiewicz W; Milewski R
    Folia Histochem Cytobiol; 2009; 47(2):275-80. PubMed ID: 19926549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.
    Pierini S; Jordanov SH; Mitkova AV; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
    Head Neck; 2014 Aug; 36(8):1103-8. PubMed ID: 23804521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
    Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
    Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Promoter methylation and expression of death-associated protein kinase gene in acute leukemia].
    Zhao WH; Meng FY; Lai YR; Peng ZG; Ma J
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Mar; 37(3):407-410. PubMed ID: 28377362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer.
    Misawa K; Mochizuki D; Imai A; Endo S; Mima M; Misawa Y; Kanazawa T; Carey TE; Mineta H
    Oncotarget; 2016 May; 7(18):26087-98. PubMed ID: 27027429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Aza-CdR can reverse gefitinib resistance caused by DAPK gene promoter methylation in lung adenocarcinoma cells.
    Yang B; Yang ZG; Gao B; Shao GG; Li GH
    Int J Clin Exp Pathol; 2015; 8(10):12961-6. PubMed ID: 26722491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival Characteristics.
    Choudhury JH; Ghosh SK
    PLoS One; 2015; 10(6):e0129808. PubMed ID: 26098903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
    Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
    Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association, clinicopathological significance, and diagnostic value of
    Shen Z; Zhou C; Li J; Deng H; Li Q; Wang J
    Onco Targets Ther; 2016; 9():6763-6773. PubMed ID: 27826202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
    Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
    Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.